Click to Share
 

Spinal Muscular Atrophy Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

By Cure SMA
Over the past few months, Cure SMA has announced a total of just over $2 million in new research funding.
By Cure SMA
Cure SMA has awarded a $304,000 drug discovery grant to Livio Pellizzoni, PhD, at Columbia University. The award is for the project, "Pharmacological Inhibition of p38αMAPK as a Candidate Therapeutic Approach for SMA." About the Project Dr.
By Cure SMA
Cure SMA has awarded a $300,000 drug discovery grant to Charlotte Sumner, MD, at Johns Hopkins University, in collaboration with Imago Pharmaceuticals.
By Cure SMA
Cure SMA has awarded a $70,000 research grant to Dr. Christine DiDonato at Lurie Children's Hospital of Chicago for her project, "Assessing mediators of muscle weakness in SMA mice." Individuals with SMA do not produce survival motor neuron (SMN) protein.
By Cure SMA
Cure SMA has awarded a $140,000 research grant to Charlotte Sumner, MD, at Johns Hopkins University for her project, "Assessing the reversibility of proximal axon abnormalities in SMA mice." Axons are long projections that grow out of motor neurons and...
By Cure SMA
Cure SMA has awarded a $50,000 clinical care research grant to Melissa Alderfer, PhD, at the Alfred I.
By Cure SMA
Cure SMA has awarded a $50,000 clinical care research grant to Tariq Rahman, PhD, at the Alfred I.
By Cure SMA
Cure SMA has awarded a $30,000 research grant to Jocelyn Cote, PhD, at the University of Ottawa for his project, "The role of SMN as a translational regulator." The grant to Dr. Cote is funded by Families of SMA Canada.
By Cure SMA
Cure SMA has awarded a $140,000 research grant to Arthur Burghes, PhD, at The Ohio State University, for his project, "Defining the contribution of RNP assembly pathways to the SMA phenotype." Because of a genetic mutation in the SMN1 gene, individuals...
By Cure SMA
Cure SMA has awarded a $90,000 research grant to Antoine Cléry, PhD, at ETH Zurich for his project, "Novel approaches against spinal muscular atrophy by targeting splicing regulators." SMA is caused by a mutation in the SMN1 gene, which regulates the...
By Cure SMA
Cure SMA has awarded a $140,000 research grant to Christine Beattie, PhD, at the Ohio State University, for her project, "Identification of SMN:HuD bound RNAs critical for motor neuron development." Because of a genetic mutation in the SMN1 gene,...
By Cure SMA
Cure SMA has awarded a $140,000 research grant to Rashmi Kothary, MD, at the Ottawa Hospital Research Institute for his project, "Muscle satellite cell biology and muscle regeneration in Smn-depleted mice." Because of a genetic mutation, individuals with.
By Cure SMA
Cure SMA has awarded a $140,000 research grant to Megerditch Kiledjian, PhD, at Rutgers, The State University of New Jersey, for his project, "Novel Strategies to Increase SMN2 RNA.” Because of a genetic mutation in the SMN1 gene, individuals with SMA...
12516539
By Cure SMA
Cure SMA and Cytokinetics Inc. (Nasdaq: CYTK), a leading muscle biology company, today announced an expanded partnership to increase education, awareness and fundraising for spinal muscular atrophy (SMA).
By Cure SMA
Cure SMA has announced a new partnership with the District Policy Group, a boutique lobbying, public policy, and advocacy practice, to advocate for several key policy areas on behalf of the SMA community.
By Cure SMA
The SMA drug pipeline has grown dramatically in just over a decade. Of the 17 programs in the pipeline, seven of these are in clinical trials, and two of those are in Phase 3 clinical trials.
By Cure SMA
Cure SMA, the leading organization dedicated to the treatment and cure of spinal muscular atrophy (SMA), recently provided an additional $445,000 grant toward a gene therapy for SMA at Nationwide Children’s Hospital.
By Cure SMA
Cure SMA has awarded a $140,000 research grant to Chad Heatwole, MD, at the University of Rochester for his project, "Development of a Clinically Relevant Outcome Measure for SMA Therapeutic Trials." This grant is supported by funding from The Spinal...
By Cure SMA
Cure SMA recently announced a new $315,000 drug discovery grant to the California Institute of Biomedical Research (CALIBR).
By Cure SMA
Cure SMA has awarded an $80,000 research grant to Linda Lowes, PT, PhD, at Nationwide Children’s Hospital for her project, “Development of An Innovative Outcome Measure to Define Disease Progression in SMA Type I for Use in the Home or Clinic.” As...

All Press Releases

By Cure SMA
Over the past few months, Cure SMA has announced a total of just over $2 million in new research funding.
By Cure SMA
Cure SMA has awarded a $304,000 drug discovery grant to Livio Pellizzoni, PhD, at Columbia University. The award is for the project, "Pharmacological Inhibition of p38αMAPK as a Candidate Therapeutic Approach for SMA." About the Project Dr.
By Cure SMA
Cure SMA has awarded a $300,000 drug discovery grant to Charlotte Sumner, MD, at Johns Hopkins University, in collaboration with Imago Pharmaceuticals.
By Cure SMA
Cure SMA has awarded a $70,000 research grant to Dr. Christine DiDonato at Lurie Children's Hospital of Chicago for her project, "Assessing mediators of muscle weakness in SMA mice." Individuals with SMA do not produce survival motor neuron (SMN) protein.
By Cure SMA
Cure SMA has awarded a $140,000 research grant to Charlotte Sumner, MD, at Johns Hopkins University for her project, "Assessing the reversibility of proximal axon abnormalities in SMA mice." Axons are long projections that grow out of motor neurons and...
By Cure SMA
Cure SMA has awarded a $50,000 clinical care research grant to Melissa Alderfer, PhD, at the Alfred I.
By Cure SMA
Cure SMA has awarded a $50,000 clinical care research grant to Tariq Rahman, PhD, at the Alfred I.
By Cure SMA
Cure SMA has awarded a $30,000 research grant to Jocelyn Cote, PhD, at the University of Ottawa for his project, "The role of SMN as a translational regulator." The grant to Dr. Cote is funded by Families of SMA Canada.
By Cure SMA
Cure SMA has awarded a $140,000 research grant to Arthur Burghes, PhD, at The Ohio State University, for his project, "Defining the contribution of RNP assembly pathways to the SMA phenotype." Because of a genetic mutation in the SMN1 gene, individuals...
By Cure SMA
Cure SMA has awarded a $90,000 research grant to Antoine Cléry, PhD, at ETH Zurich for his project, "Novel approaches against spinal muscular atrophy by targeting splicing regulators." SMA is caused by a mutation in the SMN1 gene, which regulates the...
By Cure SMA
Cure SMA has awarded a $140,000 research grant to Christine Beattie, PhD, at the Ohio State University, for her project, "Identification of SMN:HuD bound RNAs critical for motor neuron development." Because of a genetic mutation in the SMN1 gene,...
By Cure SMA
Cure SMA has awarded a $140,000 research grant to Rashmi Kothary, MD, at the Ottawa Hospital Research Institute for his project, "Muscle satellite cell biology and muscle regeneration in Smn-depleted mice." Because of a genetic mutation, individuals with.
By Cure SMA
Cure SMA has awarded a $140,000 research grant to Megerditch Kiledjian, PhD, at Rutgers, The State University of New Jersey, for his project, "Novel Strategies to Increase SMN2 RNA.” Because of a genetic mutation in the SMN1 gene, individuals with SMA...
12516539
By Cure SMA
Cure SMA and Cytokinetics Inc. (Nasdaq: CYTK), a leading muscle biology company, today announced an expanded partnership to increase education, awareness and fundraising for spinal muscular atrophy (SMA).
By Cure SMA
Cure SMA has announced a new partnership with the District Policy Group, a boutique lobbying, public policy, and advocacy practice, to advocate for several key policy areas on behalf of the SMA community.
By Cure SMA
The SMA drug pipeline has grown dramatically in just over a decade. Of the 17 programs in the pipeline, seven of these are in clinical trials, and two of those are in Phase 3 clinical trials.
By Cure SMA
Cure SMA, the leading organization dedicated to the treatment and cure of spinal muscular atrophy (SMA), recently provided an additional $445,000 grant toward a gene therapy for SMA at Nationwide Children’s Hospital.
By Cure SMA
Cure SMA has awarded a $140,000 research grant to Chad Heatwole, MD, at the University of Rochester for his project, "Development of a Clinically Relevant Outcome Measure for SMA Therapeutic Trials." This grant is supported by funding from The Spinal...
By Cure SMA
Cure SMA recently announced a new $315,000 drug discovery grant to the California Institute of Biomedical Research (CALIBR).
By Cure SMA
Cure SMA has awarded an $80,000 research grant to Linda Lowes, PT, PhD, at Nationwide Children’s Hospital for her project, “Development of An Innovative Outcome Measure to Define Disease Progression in SMA Type I for Use in the Home or Clinic.” As...
By Cure SMA
Spinal muscular atrophy (SMA) is the number one genetic cause of death for infants, and 1 in 50 people carry the genetic mutation that causes SMA. But even so, many people are not familiar with SMA. Thanks to the Cure SMA community, that is changing.
By Cure SMA
Cure SMA has awarded a $140,000 research grant to Mustafa Sahin, MD, PhD, at Boston Children’s Hospital for his project, “mTOR and Protein Synthesis in SMA.” Individuals with spinal muscular atrophy don’t produce survival motor neuron (SMN)...
By Cure SMA
Cure SMA has awarded a $140,000 research grant to Francesco Lotti, PhD, at Columbia University, for his project, "Role of Sumoylation in SMN Function and SMA Pathology." Survival motor neuron (SMN) protein is critical to the function of the nerves that...
By Cure SMA
Cure SMA, the leading organization in the US dedicated to the treatment and cure of spinal muscular atrophy (SMA), has issued a statement commending the US House of Representatives Energy and Commerce Committee for their release of the 21st Century Cures.
By Cure SMA
Cure SMA has announced a new $50,000 clinical care grant to Dr. Nilesh Mehta, for his project focusing on nutrition in spinal muscular atrophy (SMA).
By Cure SMA
Audrey Lewis founded Families of SMA, now Cure SMA, 30 years ago.
By Karen Wheeler
If you think you have limitations - STOP -There are no limitations when it comes to imagination.
By Mary Ann Liebert, Inc., publishers
To make up for insufficient amounts of SMN protein, the cause of the inherited neuromuscular disease spinal muscular atrophy (SMA), researchers have successfully delivered a replacement SMN1 gene directly to the spinal cords of animal models of SMA.
By Families of SMA
This is the fourth drug discovery project funded by Families of SMA in 2013 with a total investment of $550,000.
By Families of SMA
This funding is being awarded to Co-Principal Investigators Dr. Arthur Burghes at Ohio State University and Dr. Christian Lorson at University of Missouri.

Page:
Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share